

Oxford Biomedica wins new agreement for LentiVector platform


(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Wednesday said it had signed a new license and supply agreement on its LentiVector ...


LONDON BROKER RATINGS: BofA starts Pod Point at Buy; Barclays cuts DCC


Oxford Biomedica in license and supply deals with Novartis and Arcellx


(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck new license and supply agreements for its lentiviral vectors.


Oxford BioMedica licences technology for cystic fibrosis treatment


(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option...


LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold